000 01428 a2200409 4500
005 20250517152828.0
264 0 _c20190124
008 201901s 0 0 eng d
022 _a1527-3792
024 7 _a10.1016/j.juro.2017.04.092
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLenis, Andrew T
245 0 0 _aAdjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials.
_h[electronic resource]
260 _bThe Journal of urology
_c01 2018
300 _a43-52 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCancer Vaccines
_xtherapeutic use
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
_xtrends
650 0 4 _aClinical Trials as Topic
650 0 4 _aEvidence-Based Medicine
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xtrends
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aResearch Design
700 1 _aDonin, Nicholas M
700 1 _aJohnson, David C
700 1 _aFaiena, Izak
700 1 _aSalmasi, Amirali
700 1 _aDrakaki, Alexandra
700 1 _aBelldegrun, Arie
700 1 _aPantuck, Allan
700 1 _aChamie, Karim
773 0 _tThe Journal of urology
_gvol. 199
_gno. 1
_gp. 43-52
856 4 0 _uhttps://doi.org/10.1016/j.juro.2017.04.092
_zAvailable from publisher's website
999 _c27148889
_d27148889